A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...

Liquid Biopsy MarketThe global liquid biopsy market is projected to experience remarkable growth, with an estimated revenue ...

In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three ...

Pancreatic incidentalomas can be detected in their early stage using a less invasive method to provide proper prognosis and ...

Results of a study recently published in the journal JCO Precision Oncology show that in the clinical trial context, combined ...

In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of ...

Co-authored by investigators of VHIO's Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results of a ...

Two posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation of CTCs ...

The research highlights the potential of liquid biopsy, a minimally invasive test that analyzes blood for circulating tumor DNA, genetic predispositions, and cancer-specific biomarkers.

These findings will be presented at the American Association for Cancer Research Special Conference in Cancer Research: Liquid Biopsy from November 13-16, 2024, in San Diego, Calif. A new study ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...